Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Dastgerdi NK"'
Autor:
Dastgerdi NK; Division of Molecular Therapeutics and Formulation, School of Pharmacy, University of Nottingham, NG7 2RD, UK; Department of Pharmaceutics, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran., Dastgerdi NK; Pharmaceutical Sciences Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran., Bayraktutan H; Division of Molecular Therapeutics and Formulation, School of Pharmacy, University of Nottingham, NG7 2RD, UK., Costabile G; Department of Pharmacy, University of Napoli Federico II, Napoli, Italy., Atyabi F; Department of Pharmaceutics, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran; Nanotechnology Research Centre, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran 1417614315, Iran., Dinarvand R; Department of Pharmaceutics, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran; Nanotechnology Research Centre, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran 1417614315, Iran. Electronic address: dinarvand@tums.ac.ir., Longobardi G; Department of Pharmacy, University of Napoli Federico II, Napoli, Italy., Alexander C; Division of Molecular Therapeutics and Formulation, School of Pharmacy, University of Nottingham, NG7 2RD, UK., Conte C; Department of Pharmacy, University of Napoli Federico II, Napoli, Italy. Electronic address: claudia.conte@unina.it.
Publikováno v:
International journal of pharmaceutics [Int J Pharm] 2024 Sep 30; Vol. 663, pp. 124545. Date of Electronic Publication: 2024 Aug 02.
Autor:
Dastgerdi NK; Division of Molecular Therapeutics and Formulation, School of Pharmacy, University of Nottingham NG7 2RD UK cameron.alexander@nottingham.ac.uk.; Department of Pharmaceutical Nanotechnology, School of Pharmacy, Tehran University of Medical Sciences Tehran Iran., Gumus N; Division of Molecular Therapeutics and Formulation, School of Pharmacy, University of Nottingham NG7 2RD UK cameron.alexander@nottingham.ac.uk., Bayraktutan H; Division of Molecular Therapeutics and Formulation, School of Pharmacy, University of Nottingham NG7 2RD UK cameron.alexander@nottingham.ac.uk., Jackson D; School of Life Sciences, Faculty of Medicine & Health Sciences, University of Nottingham NG7 2RD UK., Polra K; Department of Infectious Diseases, Section of Immunology of Infection, Imperial College London Norfolk Place London W21PG UK., McKay PF; Department of Infectious Diseases, Section of Immunology of Infection, Imperial College London Norfolk Place London W21PG UK., Atyabi F; Department of Pharmaceutical Nanotechnology, School of Pharmacy, Tehran University of Medical Sciences Tehran Iran., Dinarvand R; Department of Pharmaceutical Nanotechnology, School of Pharmacy, Tehran University of Medical Sciences Tehran Iran.; Nanotechnology Research Centre, Faculty of Pharmacy, Tehran University of Medical Sciences Tehran 1417614315 Iran., Shattock RJ; Department of Infectious Diseases, Section of Immunology of Infection, Imperial College London Norfolk Place London W21PG UK., Martinez-Pomares L; School of Life Sciences, Faculty of Medicine & Health Sciences, University of Nottingham NG7 2RD UK., Gurnani P; UCL School of Pharmacy, University College London 29-39 Brunswick Square London WC1N 1AX UK p.gurnani@ucl.ac.uk., Alexander C; Division of Molecular Therapeutics and Formulation, School of Pharmacy, University of Nottingham NG7 2RD UK cameron.alexander@nottingham.ac.uk.
Publikováno v:
Nanoscale advances [Nanoscale Adv] 2024 Jan 24; Vol. 6 (5), pp. 1409-1422. Date of Electronic Publication: 2024 Jan 24 (Print Publication: 2024).